...
首页> 外文期刊>Vaccine >Efficacy of DNA-hsp65 vaccination for tuberculosis varies with method of DNA introduction in vivo
【24h】

Efficacy of DNA-hsp65 vaccination for tuberculosis varies with method of DNA introduction in vivo

机译:DNA-hsp65疫苗接种对结核病的功效随体内DNA导入方法的不同而不同

获取原文
获取原文并翻译 | 示例
           

摘要

A DNA vaccine codifying the mycobacterial hsp65 can prevent infection with Mycobacterium tuberculosis in a prophylactic setting and also therapeutically reduce the number of bacteria in infected mice. The protective mechanism is thought to be related to Th1-mediated events that result in bacterial killing. To determine the best method of hsp65 introduction for vaccination efficacy against tuberculosis (TB), we evaluated the immunogenicity and protection of DNA-hsp65 administered by gene gun bombardment or intramuscular (i.m.) injection of naked DNA. Immunization by gene gun induced immune response with plasmid doses 100-fold lower than those required for intramuscular immunization. However, in contrast to intramuscular immunization, which was protective in these studies, gene gun immunization did not protect BALB/c mice against challenge infection
机译:编码分枝杆菌hsp65的DNA疫苗可在预防性环境中预防结核分枝杆菌感染,还可以减少感染小鼠的细菌数量。认为该保护机制与导致细菌杀死的Th1介导的事件有关。为了确定导入hsp65的最佳方法以预防结核病(TB)的疫苗接种效果,我们评估了通过基因枪轰击或肌肉内(i.m.)裸露DNA注射对DNA-hsp65的免疫原性和保护作用。通过基因枪进行的免疫诱导的免疫应答,其质粒剂量比肌内免疫所需的剂量低100倍。但是,与在这些研究中具有保护作用的肌内免疫相反,基因枪免疫不能保护BALB / c小鼠免受挑战性感染

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号